News Industry News DalCor Pharma licenses a late-stage investigational cardiovascular drug following major discovery by Montreal Heart Institute (MHI) scientists June 08, 2015
News Conference News ACC 2014 HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues Jason Kahn March 31, 2014